metformin and megestrol acetate
metformin has been researched along with megestrol acetate in 14 studies
Research
Studies (14)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (14.29) | 29.6817 |
2010's | 8 (57.14) | 24.3611 |
2020's | 4 (28.57) | 2.80 |
Authors
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Lin, JF; Shen, ZQ; Zhu, HT | 1 |
Kim, MK; Seong, SJ | 1 |
Chen, X; Gu, C; Luo, X; Ning, C; Shan, W; Wang, C; Zhang, Z; Zhou, Q | 1 |
Bidadi, S; Foroughi, M; Ghojazadeh, M; Melli, MS; Tabrizi, AD | 1 |
Atiomo, W; Clement, NS; Mulvaney, CA; Oliver, TR; Sanner, JR; Shiwani, H | 1 |
Chen, X; Luo, X; Ning, C; Shan, W; Shi, Y; Xie, B; Xie, L; Xu, Y; Yang, B; Zhang, H; Zhu, Q | 1 |
Chen, XJ; Cheng, YL; Du, Y; Guan, J; Gulinazi, Y; Liu, J; Luo, XZ; Ma, FH; Ning, CC; Shan, WW; Sun, L; Yang, BY; Yu, M; Zhang, HW; Zhu, Q | 1 |
Atiomo, W | 1 |
Aghajani, R; Arab, M; Ghahghaei-Nezamabadi, A; Khalagi, K; Sadeghi, S; Tehranian, A | 1 |
Liu, Z; Niu, J; Shi, C; Zhao, X | 1 |
Reviews
1 review(s) available for metformin and megestrol acetate
Article | Year |
---|---|
Metformin for endometrial hyperplasia.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Disease Progression; Endometrial Hyperplasia; Female; Humans; Hysterectomy; Megestrol Acetate; Metformin; Middle Aged; Precancerous Conditions; Randomized Controlled Trials as Topic; Recurrence; Uterine Hemorrhage; Uterine Neoplasms | 2017 |
Trials
5 trial(s) available for metformin and megestrol acetate
Article | Year |
---|---|
Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia.
Topics: Adult; Antineoplastic Agents, Hormonal; Drug Therapy, Combination; Endometrial Hyperplasia; Female; Humans; Hypoglycemic Agents; Megestrol Acetate; Metabolic Syndrome; Metformin; Pilot Projects; Receptors, Estrogen; Receptors, Progesterone; Single-Blind Method; Treatment Outcome | 2014 |
Antiproliferative effect of metformin on the endometrium--a clinical trial.
Topics: Adult; Antineoplastic Agents, Hormonal; Atrophy; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Hypoglycemic Agents; Megestrol Acetate; Metformin; Metrorrhagia | 2014 |
Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial.
Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; China; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Megestrol Acetate; Metformin; Middle Aged; Treatment Outcome; Young Adult | 2020 |
The impact of adjunctive metformin to progesterone for the treatment of non-atypical endometrial hyperplasia in a randomized fashion, a placebo-controlled, double blind clinical trial.
Topics: Adult; Antineoplastic Agents, Hormonal; Double-Blind Method; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Metformin | 2021 |
Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial pr
Topics: Antineoplastic Combined Chemotherapy Protocols; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Metformin; Obesity; Pregnancy; Prospective Studies; Randomized Controlled Trials as Topic | 2022 |
Other Studies
8 other study(ies) available for metformin and megestrol acetate
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Reverse of progestin-resistant atypical endometrial hyperplasia by metformin and oral contraceptives.
Topics: Adult; Contraceptives, Oral, Hormonal; Endometrial Hyperplasia; Female; Humans; Hypoglycemic Agents; Megestrol Acetate; Metformin; Progestins | 2008 |
Conservative treatment for atypical endometrial hyperplasia: what is the most effective therapeutic method?
Topics: Antineoplastic Agents, Hormonal; Endometrial Hyperplasia; Female; Humans; Hypoglycemic Agents; Megestrol Acetate; Metformin | 2014 |
Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer.
Topics: Administration, Oral; Adult; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysteroscopy; Megestrol Acetate; Metformin; Middle Aged; Progestins; Retrospective Studies; Treatment Outcome; Young Adult | 2019 |
Is there any move to use metformin for endometrial hyperplasia in routine clinical practice?
Topics: Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Hypoglycemic Agents; Megestrol Acetate; Metformin | 2020 |